Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-3.77%
2024146.48%
202317.48%
202261.33%
2021128.61%
2020291.95%
2019476.27%
20180.00%